Bryan S, Afful J, Carroll M, Te-Ching C, Orlando D, Fink S, et al. NHSR 158. National Health and Nutrition Examination Survey 2017–March 2020 Pre-pandemic Data Files. Hyattsville, MD, https://doi.org/10.15620/cdc:106273 2021.

Castillo JJ, Mulkey F, Geyer S, Kolitz JE, Blum W, Powell BL, et al. Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials. Am J Hematol. 2016;91:199–204.

Article  PubMed  Google Scholar 

Poynter JN, Richardson M, Blair CK, Roesler MA, Hirsch BA, Nguyen P, et al. Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes. Cancer Epidemiol. 2016;40:134–40.

Article  PubMed  Google Scholar 

Li S, Chen L, Jin W, Ma X, Ma Y, Dong F, et al. Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis. Sci Rep. 2017;7:17998.

Article  PubMed  PubMed Central  Google Scholar 

Brunner AM, Sadrzadeh H, Feng Y, Drapkin BJ, Ballen KK, Attar EC, et al. Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemia. Am J Hematol. 2013;88:642–6.

Article  PubMed  PubMed Central  Google Scholar 

Tavitian S, Denis A, Vergez F, Berard E, Sarry A, Huynh A, et al. Impact of obesity in favorable-risk AML patients receiving intensive chemotherapy. Am J Hematol. 2016;91:193–8.

Article  PubMed  Google Scholar 

Medeiros BC, Othus M, Estey EH, Fang M, Appelbaum FR. Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia. Haematologica. 2012;97:1401–4.

Article  PubMed  PubMed Central  Google Scholar 

Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, et al. Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old. N Engl J Med. 2006;355:763–78.

Article  CAS  PubMed  Google Scholar 

Enßle JC, Wolf S, Scheich S, Weber S, Kramer M, Ruhnke L, et al. Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience. Br J Cancer. 2023;129:1126–33.

Article  PubMed  PubMed Central  Google Scholar 

Pedersen MH, Bøgelund M, Dirksen C, Johansen P, Jørgensen NB, Madsbad S, et al. The prevalence of comorbidities in Danish patients with obesity – A Danish register‐based study based on data from 2002 to 2018. Clin Obes 12. https://doi.org/10.1111/cob.12542 2022.

Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang Y-B, et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol. 2013;31:2607–18.

Article  PubMed  PubMed Central  Google Scholar 

Piché M-E, Tchernof A, Després J-P. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 2020;126:1477–1500.

Article  PubMed  Google Scholar 

Andreyeva T, Sturm R, Ringel JS. Moderate and severe obesity have large differences in health care costs. Obes Res. 2004;12:1936–43.

Article  PubMed  Google Scholar 

Garcia-Manero G, Podoltsev NA, Othus M, Pagel JM, Radich JP, Fang M, et al. A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML. Leukemia. 2024;38:58–66.

Article  CAS  PubMed  Google Scholar 

Dhakal P, Lyden E, Lee A, Michalski J, Al-Kadhimi ZS, Maness LJ, et al. Effects of obesity on overall survival of adults with acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2020;20:e131–6.

Article  PubMed  Google Scholar 

Kitahara CM, Flint AJ, Berrington de Gonzalez A, Bernstein L, Brotzman M, MacInnis RJ, et al. Association between class III obesity (BMI of 40–59 kg/m2) and mortality: a pooled analysis of 20 prospective studies. PLoS Med. 2014;11:e1001673.

Article  PubMed  PubMed Central  Google Scholar 

Powell-Wiley TM, Poirier P, Burke LE, Després J-P, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 143. https://doi.org/10.1161/CIR.0000000000000973 2021.

Carbone S, Canada JM, Billingsley HE, Siddiqui MS, Elagizi A, Lavie CJ. Obesity paradox in cardiovascular disease: where do we stand? Vasc Health Risk Manag. 2019;15:89–100.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carbone S, Billingsley HE, Rodriguez-Miguelez P, Kirkman DL, Garten R, Franco RL, et al. Lean mass abnormalities in heart failure: the role of sarcopenia, sarcopenic obesity, and cachexia. Curr Probl Cardiol. 2020;45:100417.

Article  PubMed  Google Scholar 

Emami A, Saitoh M, Valentova M, Sandek A, Evertz R, Ebner N, et al. Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure (SICA‐HF). Eur J Heart Fail. 2018;20:1580–7.

Article  CAS  PubMed  Google Scholar 

Griggs JJ, Bohlke K, Balaban EP, Dignam JJ, Hall ET, Harvey RD, et al. Appropriate systemic therapy dosing for obese adult patients with cancer: ASCO guideline update. J Clin Oncol. 2021;39:2037–48.

Article  PubMed  Google Scholar 

Lin A, Othus M, McQuary A, Chi M, Estey E. Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemia. Leuk Lymphoma. 2013;54:541–6.

Article  PubMed  Google Scholar 

Doney K, McMillen K, Buono L, Deeg HJ, Gooley T. Impact of body mass index on outcomes of hematopoietic stem cell transplantation in adults. Biol Blood Marrow Transplant. 2019;25:613–20.

Article  PubMed  Google Scholar 

Yu J, Lin S, Luo Y, Shi J, Tan Y, Lai X, et al. Obesity is correlated with poor outcome after allogeneic hematopoietic stem cell transplantation in patients with acute leukemia. Jpn J Clin Oncol. 2020;50:889–96.

Article  PubMed  Google Scholar 

Voshtina E, Szabo A, Hamadani M, Fenske TS, D’Souza A, Chhabra S, et al. Impact of obesity on clinical outcomes of elderly patients undergoing allogeneic hematopoietic cell transplantation for myeloid malignancies. Biol Blood Marrow Transpl. 2019;25:e33–8.

Article  Google Scholar 

Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Navarro WH, Agovi M-A, Logan BR, Ballen K, Bolwell BJ, Frangoul H, et al. Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults. Biol Blood Marrow Transpl. 2010;16:1442–50.

Article  Google Scholar 

Brauer D, Backhaus D, Pointner R, Vucinic V, Niederwieser D, Platzbecker U, et al. Nutritional status at diagnosis and pre-transplant weight loss impact outcomes of acute myeloid leukemia patients following allogeneic stem cell transplantation. HemaSphere. 2021;5:e532.

Article  PubMed  PubMed Central  Google Scholar